September 21, 2017
Track this case
F. Dennis Saylor, IV
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Tweaks to a generic opioid’s labeling did not warrant OxyContin maker Purdue Pharma LP to file a separate lawsuit repeating extant patent infringement claims, a federal judge decided in a Boston court hearing Tuesday.
Already a subscriber? Click here to login